Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
Kim J, Koh DI, Lee M, Park YS, Hong SW, Shin JS, Lee MS, Kim MH, Lee JH, Jeong J, Bae S, Hong JK, Jeong HR, Ryu YS, Kim SM, Choi M, Kim H, Ryu H, Hur SC, Park J, Hur DY, Jin DH.
Kim J, et al. Among authors: koh di.
Cell Death Differ. 2023 Dec;30(12):2491-2507. doi: 10.1038/s41418-023-01235-9. Epub 2023 Nov 6.
Cell Death Differ. 2023.
PMID: 37926711
Free PMC article.